Pura Vida Investments’s Stemline Therapeutics, Inc. STML Stock Holding History

Pura Vida Investments’s Portfolio STML Stock Details STML Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-132,422	Closed	-$1.38M	–	137
2019 Q3	$1.38M	Sell	132,422 -21,176	-14%	-$277K	0.24%	77
2019 Q2	$2.35M	Buy	153,598 +115,514	+303%	+$1.67M	0.36%	80
2019 Q1	$489K	Buy	+38,084	New	+$431K	0.07%	99
2017 Q4	–	Sell	-60,000	Closed	-$666K	–	109
2017 Q3	$666K	Hold	60,000	–	–	0.19%	73
2017 Q2	$552K	Hold	60,000	–	–	0.22%	60
2017 Q1	$513K	Buy	+60,000	New	+$547K	0.15%	72

Other funds holding STML

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Pura Vida Investments's STML Position: Q4 2019 in Review

Pura Vida Investments sold out of Stemline Therapeutics, Inc. (STML) in Q4 2019, closing a stake of 132,422 shares — an estimated $1.38M sold.

Pura Vida Investments first reported a position in STML in Q1 2017 and held it in 6 quarters. The position peaked at $2.35M in Q2 2019. 99 funds tracked by Wall St. Rank hold STML as of Q4 2019.

Pura Vida Investments reported no remaining Stemline Therapeutics, Inc. position as of Q4 2019 after selling out during the quarter.
Pura Vida Investments sold 132,422 Stemline Therapeutics, Inc. shares in Q4 2019, an estimated $1.38M.
Pura Vida Investments first reported a position in Stemline Therapeutics, Inc. in Q1 2017 and held it in 6 quarters.
Pura Vida Investments's Stemline Therapeutics, Inc. position peaked at $2.35M in Q2 2019.
99 funds tracked by Wall St. Rank held Stemline Therapeutics, Inc. as of Q4 2019.

Based on Pura Vida Investments's 13F filing for Q4 2019, filed 14 Feb 2020.